Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: European Surgery 4/2022

15.06.2021 | case report

Delayed presentation of inflammatory breast carcinoma during the COVID-19 pandemic

verfasst von: MD Daniele Bernardi, MD Emanuele Asti, MD Giulia Bonavina, MD Alberto Luporini, MD Claudio Clemente, MD, FACS Prof. Luigi Bonavina

Erschienen in: European Surgery | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Breast cancer may present with distinct cutaneous manifestations that may be paraneoplastic or secondary to direct skin infiltration, distant skin metastases, or dermal lymphatic tumor embolization (inflammatory breast carcinoma).

Case report

A 51-year-old Asian woman visited the emergency care department during the outbreak of COVID-19 in Northern Italy. About 6 months before, she had noted the onset of right breast swelling accompanied by skin redness and itching. She never consulted a physician, and, over time, the local skin condition progressed to a large scaly plaque covering the entire breast surface including the nipple. At presentation, abduction of the right upper limb was impaired due to severe shoulder pain. CT scan showed the presence of bilateral breast masses with necrotic and colliquative features, and multiple skeletal, nodal, pulmonary, and brain images suggestive of metastases. An ultrasound-guided core biopsy of the contralateral breast showed grade 2 non-special type infiltrating carcinoma. The patient was referred to the breast oncology unit and is currently being treated with aromatase inhibitors and chemotherapy.

Conclusion

The COVID-19 pandemic has disrupted the entire spectrum of oncological care including breast cancer. Hopefully, telemedicine will contribute to increase patients’ confidence and will provide earlier diagnosis and treatment while minimizing the risk of contagion.
Literatur
1.
Zurück zum Zitat Tan AR. Cutaneous manifestations of breast cancer. Semin Oncol. 2016;43:331–4. CrossRef Tan AR. Cutaneous manifestations of breast cancer. Semin Oncol. 2016;43:331–4. CrossRef
2.
Zurück zum Zitat Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75. CrossRef Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer. The disease, the biology, the treatment. CA Cancer J Clin. 2010;60:351–75. CrossRef
3.
Zurück zum Zitat Song YJ, Wu YF, Fan T. Dermatosis as the initial manifestation of malignant breast tumors: retrospective analysis of 4 cases. Breast Care. 2010;5:174–6. CrossRef Song YJ, Wu YF, Fan T. Dermatosis as the initial manifestation of malignant breast tumors: retrospective analysis of 4 cases. Breast Care. 2010;5:174–6. CrossRef
4.
Zurück zum Zitat Lakhani SR, Ellis IO, Schnitt SJ, et al., editors. WHO classification of tumours of the breast. 4th ed. WHO classification of tumours series, Vol. 4. Lyon: International Agency for Research on Cancer; 2012. http://​publications.​iarc.​fr/​14. Lakhani SR, Ellis IO, Schnitt SJ, et al., editors. WHO classification of tumours of the breast. 4th ed. WHO classification of tumours series, Vol. 4. Lyon: International Agency for Research on Cancer; 2012. http://​publications.​iarc.​fr/​14.
5.
Zurück zum Zitat Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26. CrossRef Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26. CrossRef
6.
Zurück zum Zitat Sud A, Jones ME, Broggio J, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020;31(8):1065–74. CrossRef Sud A, Jones ME, Broggio J, et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020;31(8):1065–74. CrossRef
7.
Zurück zum Zitat Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the Covid-19 pandemic on cancer care. Nat Cancer. 2020;1:565–7. CrossRef Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the Covid-19 pandemic on cancer care. Nat Cancer. 2020;1:565–7. CrossRef
8.
Zurück zum Zitat Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo O. Breast cancer diagnosis in coronavirus era: alert from Italy. Front Oncol. 2020;10:938. CrossRef Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo O. Breast cancer diagnosis in coronavirus era: alert from Italy. Front Oncol. 2020;10:938. CrossRef
10.
Zurück zum Zitat Van Huden DJP, van Maaren MC, Strobbe LJA, et al. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer. Breast Cancer Res. 2019;21:113. CrossRef Van Huden DJP, van Maaren MC, Strobbe LJA, et al. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer. Breast Cancer Res. 2019;21:113. CrossRef
11.
Zurück zum Zitat Kalli S, Freer PE, Rafferty EA. Lesions of the skin and superficial tissue at breast MR imaging. Radiographics. 2010;30:1981–1913. CrossRef Kalli S, Freer PE, Rafferty EA. Lesions of the skin and superficial tissue at breast MR imaging. Radiographics. 2010;30:1981–1913. CrossRef
12.
Zurück zum Zitat Le-Petross HT, Cristofanilli M, Carkaci S, et al. MRI features of inflammatory breast cancer. AJR. 2011;197:W769–W76. CrossRef Le-Petross HT, Cristofanilli M, Carkaci S, et al. MRI features of inflammatory breast cancer. AJR. 2011;197:W769–W76. CrossRef
13.
Zurück zum Zitat Cheatle GL. Clinical remarks on the early recognition of cancer of the breast. BMJ. 1906;1:1205–10. CrossRef Cheatle GL. Clinical remarks on the early recognition of cancer of the breast. BMJ. 1906;1:1205–10. CrossRef
14.
Zurück zum Zitat Pekar G, Hofmeyer S, Tabar L, et al. Multifocal breast cancer documented in large-format histology sections. Cancer. 2013;119:1132–9. CrossRef Pekar G, Hofmeyer S, Tabar L, et al. Multifocal breast cancer documented in large-format histology sections. Cancer. 2013;119:1132–9. CrossRef
15.
Zurück zum Zitat Tot T. Diffuse invasive breast carcinoma of no special type. Virchows Arch. 2016;468:199–206. CrossRef Tot T. Diffuse invasive breast carcinoma of no special type. Virchows Arch. 2016;468:199–206. CrossRef
Metadaten
Titel
Delayed presentation of inflammatory breast carcinoma during the COVID-19 pandemic
verfasst von
MD Daniele Bernardi
MD Emanuele Asti
MD Giulia Bonavina
MD Alberto Luporini
MD Claudio Clemente
MD, FACS Prof. Luigi Bonavina
Publikationsdatum
15.06.2021
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2022
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-021-00726-8